Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Prevention of Ketamine-Induced Psychosis in Children
NCT00205712Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2003
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in substance-induced psychosis (SIPD) comparing Ketamine + Dexmedetomidine with Ketamine + Placebo (2 arms). Primary endpoint: Brief Psychiatric Ratings Scale Positive Symptom Subscale Score. Started Feb 2003; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
substance-induced psychosis (SIPD)
Beyond the preview
Go deeper on NCT00205712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00205712.